Fmoc-L-Lys(Dde)-OH

Fmoc-L-Lys(Dde)-OH is an Fmoc-protected lysine derivative bearing a Dde-protected side-chain amine, retaining the L-configuration at the alpha stereocenter and providing orthogonal protection for stepwise peptide assembly. The molecule contains an Fmoc carbamate on the alpha-amino group, a free carboxylic acid for C-terminal coupling, and a Dde-protected epsilon-amino functionality that remains masked under standard peptide coupling conditions but can be selectively removed when orthogonal deprotection is required. The presence of two protection elements with distinct deprotection behavior supports controlled construction of lysine-containing peptides and lysine-rich sequences, including sites for later side-chain functionalization. The resulting amino acid building block functions as a chiral, protected intermediate that participates in peptide coupling chemistry while enabling downstream conversion of the lysine side chain into reactive amine-bearing derivatives.

1. Peptide Synthesis

Fmoc-L-Lys(Dde)-OH is used in solid-phase peptide synthesis where the Fmoc group enables iterative N-terminal deprotection and coupling cycles while the carboxylic acid supports formation of amide bonds to the growing peptide chain. The lysine side chain is protected as a Dde carbamate, allowing the epsilon-amine to remain inert during routine coupling steps and minimizing undesired branching or crosslinking. Orthogonal deprotection of the Dde group can be applied to generate a selectively exposed lysine side-chain amine for targeted post-assembly modifications such as additional acylation, alkylation, or conjugation. Lysine incorporation with controlled side-chain availability supports preparation of peptides with defined charge density and functional handles for subsequent biochemical or materials-oriented studies, aligning with standard amino acid and peptide chemistry workflows.

2. Bioconjugation Chemistry

Fmoc-L-Lys(Dde)-OH is suitable for bioconjugation strategies that require lysine side-chain amine presentation at a defined stage of synthesis. The protected epsilon-amine under Dde masking helps maintain chemoselectivity during peptide assembly, while the free alpha-carboxylic acid and Fmoc-protected backbone facilitate integration into peptide scaffolds that can later be converted into conjugation-ready constructs. Selective Dde deprotection can generate a primary amine for coupling reactions to electrophiles such as activated esters, isothiocyanates, aldehydes, or other amine-reactive bioconjugation partners used in labeling and functionalization workflows. The stereochemically defined lysine residue supports reproducible spacing of cationic sites and conjugation points in peptide-based probes, enabling downstream formation of labeled biomolecules and structured conjugates.

3. Side-Chain Functionalization

Fmoc-L-Lys(Dde)-OH supports side-chain functionalization routes in synthetic organic chemistry by providing an orthogonally protected lysine platform with a masked epsilon-amine that can be revealed under conditions compatible with other protecting groups. The Dde-protected lysine side chain can be transformed after peptide assembly into a range of derivatives including acylated amines, urea/amide linkages, or tethered functional groups that modulate polarity and reactivity. The Fmoc-controlled alpha-amino protection enables consistent incorporation into peptide building blocks, while the carboxylic acid functionality allows controlled coupling to generate intermediates suitable for further derivatization. Downstream conversion to amine-bearing lysine analogs supports construction of peptidomimetic fragments, affinity tags, and chemical handles used for structure-guided optimization in amino acid derivatization programs.

4. Drug Discovery Chemistry

Fmoc-L-Lys(Dde)-OH is applied in drug discovery chemistry for preparing lysine-containing peptide fragments and peptidomimetic scaffolds used in structure-activity relationship studies. The chiral lysine core and orthogonal protection pattern enable systematic variation of side-chain chemistry while maintaining a consistent backbone architecture for SAR comparisons. The Dde-protected epsilon-amine can be selectively unmasked to introduce functional groups that tune hydrogen-bonding capacity, basicity, and steric profile, supporting medicinal chemistry exploration of binding-site interactions. The Fmoc/acid functionality also supports scalable synthesis of defined intermediates for fragment libraries and analog generation, linking protected amino acid chemistry to downstream molecular design and optimization workflows.

5. Pharmaceutical Manufacturing

Fmoc-L-Lys(Dde)-OH is relevant to pharmaceutical manufacturing workflows that rely on protected amino acid intermediates for controlled peptide or peptide-like intermediate production. The orthogonal Fmoc and Dde protection strategy supports robust process design by enabling predictable sequence assembly and later exposure of the lysine side-chain amine for controlled downstream transformations. The presence of a free carboxylic acid and a protected alpha-amino group supports standard peptide coupling logic used in manufacturing-scale synthesis of peptide intermediates and defined functionalized fragments. The resulting ability to manage chemoselectivity during stepwise processing can be applied to produce reproducible peptide building blocks and side-chain-modified intermediates used in applied product development and specialty chemical production.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active